Search results

Activated partial thromboplastin time (APTT) is a commonly used screening test for haemostatic defects in the intrinsic and common pathway of the coagulation cascade, as well as the contact activation system.

Photometer permits the real-time follow-up of light transmittance (900 nm wavelength) in independent tubes thermostated at 37°C. The intuitive software interface allows real-time monitoring of the derivation curve: the LysisTime. Excellent reproducibility over time for the GFC-Test and GFC Control Plasmas, evidenced by low inter- and intra-test coefficients of variation (< 5 %). Further information is provided in our brochure "Rapid and efficient measurement of global fibrinolytic capacity (GFC)"

Abnormal control for activated partial thromboplastin time (aPTT) assays.

In vitro qualitative determination of thrombin time in human citrated plasma, using a manual or automated method.

Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.

Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.

Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.

Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.

Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.

Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.